NRx Pharmaceuticals (NASDAQ: NRXP)
NRx Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
NRx Pharmaceuticals Company Info
NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.
News & Analysis
Why NRx Pharmaceuticals Stock Soared Today
Investors are intrigued by the potential of the drugmaker's experimental coronavirus therapy.
Why NRX Pharmaceuticals Stock Is Jumping Today
The company received good news from the FDA.
1 Small-Cap Stock With 10X Potential
This company's coronavirus efforts could pay off big time.
Why NRx Pharmaceuticals Stock Is Tumbling Today
The drugmaker is being sued by Relief Therapeutics.
Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday
New clinical trial results bode well for aviptadil in treating critically ill COVID-19 patients.
Why NRx Pharmaceuticals Stock Is Skyrocketing Today
The company announced progress on two fronts for its experimental COVID-19 drug Zyesami.
Why NRx Pharmaceuticals Stock Vaulted Higher Today
Investors cheered reports in Israel that COVID-19 vaccine candidate BriLife appears to provide protection for at least six months after a second dose.
Why NRx Pharmaceuticals Stock Is Sinking Today
The company announced a price placement for more than 2.7 million new shares and stock options.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.